The
Protein Folding Problem.
Understanding how a protein’s sequence determines
its three-dimensional structure, and consequently,
its function is a fundamental problem of modern
biology. Solving this problem, known as the protein
folding problem, becomes more urgent as an
increasing number of human diseases and conditions
are discovered to be caused by misfolded proteins.
Among these diseases are Alzheimer’s Disease (and
related prion diseases), Parkinson’s Disease, and
cystic fibrosis. Furthermore, we are beginning to
understand that when certain proteins, including the
p53 tumor suppressor protein, are incorrectly folded
due to genetic alteration they are unable to perform
their role in the immune system, leading to an
increased susceptibility to a variety of human
cancers. Therefore, solving the protein folding
problem holds great promise to improve human
health.
Great progress has been made in the study
of protein folding by studying relatively simple
proteins and peptides under highly controlled
experimental conditions. The combination of a
variety of biophysical and biochemical techniques,
including (but not limited to) fluorescence,
ultraviolet and NMR spectroscopy, site-directed
mutagenesis, and chemical modification, has been
very successful at determining the fundamental
principles of protein folding when applied to model
protein systems. In fact, the field has developed
to the point where it is possible to begin applying
the techniques and principles derived for use on
these simple proteins to more complicated proteins
involved in various metabolic processes. Two
biological processes that I have chosen to study
using protein folding techniques are 1) how cells
repair oxidative damage and 2) how the intracellular
levels of free iron are regulated.
Repair of oxidative damage by the enzyme methionine
sulfoxide reductase.
An inevitable consequence of living in an
aerobic environment is dealing with damage caused by
reactive oxygen species, such as superoxide,
hydrogen peroxide, the hydroxyl ion and water.
Modification of proteins, DNA and lipid molecules by
reactive oxygen species has been shown to contribute
to human disease and the aging process. Although
most of these covalent changes, such as DNA
crosslinking and protein fragmentation, are
irreversible, two types of protein modifications,
cysteine and methionine oxidation, can be reversed
enzymatically. The process by which protein
disulfide isomerases reduce cysteine crosslinks
(disulfide bridges) is fairly well-understood, but
much less is known about methionine sulfoxide
reductase (MsrA), the enzyme that reduces methionine
sulfoxide back to methionine and restores function
to the damaged protein. Although MsrA is an
essential protein – it has been found in the genome
of every organism sequenced to date – we are just beginning to understand
how it works.
Some of the unanswered questions that I
plan to address are: How does MsrA recognize and
repair proteins that contain oxidized methionine
residues? How is MsrA able to interact with such a
variety of proteins? What are the biophysical
properties of MsrA? What are the thermodynamic
parameters of the folding reaction of MsrA and how
can we use them to help us understand the physical
features that stabilize the protein? I will use the
experimental techniques described below to explore
these and other issues.
The figure at left is a three-dimensional
representation of bovine peptide methionine
sulfoxide reductase (PDB file 1FVG). (Image produced
using WebLab ViewerLite.)
The
role of iron-responsive element protein 1/aconitase
in mammalian iron regulation.
Although it was thought for many years
that each gene produced a single protein with a
single function, this simplistic view has been
overturned by the discovery of a number of proteins
that perform different functions depending on such
factors as cell type, changes in oligomeric state,
or the cellular concentration of a certain ligand.
One such protein that has two distinct jobs is the
mammalian iron-responsive element protein 1 (IRP-1),
which plays an important role in the regulation of
intracellular iron regulation. When iron levels are
low, IRP-1 bind to regions of mRNA known as
iron-responsive elements and by doing so, causes the
levels of iron to rise by either up-regulating or
down-regulating the production of proteins involved
in iron transport and storage. When the iron
concentration is restored to normal levels, IRP-1
assumes its other identity – that of a cytoplasmic
aconitase. (Aconitase, an enzyme in the TCA cycle,
is normally found in the mitochondria rather than
the cytoplasm.) As an aconitase, it can no longer
bind to RNA and has a structural feature not found
in IRP-1: a [4Fe-4S] iron-sulfur cluster.
Cytoplasmic aconitase also catalyzes the
isomerization of citrate to isocitrate, just like
its mitochondrial counterpart.
I am interested in studying how IRP-1/aconitase
converts between its two active forms. What is the
relatively stability (free energy) of these two
forms? Can we learn about the conversion process by
determining how these proteins unfold? What is the
effect of mRNA on the stability on IRP-1?
Conversely, what is the effect of the iron-sulfur
cluster and the natural substrate citrate on the
stability of the cytoplasmic aconitase? Using
techniques described below, I will investigate these
and other questions.
Figure at right depicts pig heart
mitochondrial aconitase (PDB file 7ACN), which is
assumed to be homologous in structure to the
cytoplasmic form. (This figure was generated using
WebLab ViewerLite.)
Experimental approach
Over the
years, a number of useful experimental methods have
been developed to study protein folding. Many of
these are simple but highly informative. One such
approach is to incrementally denature a protein, by
chemical or thermal methods, and monitor its
spectroscopic properties at each step. The
spectroscopic property can then be plotted as a
function of denaturant concentration or
temperature. If the denaturation is performed in a
reversible manner, it is possible to extract
thermodynamic parameters from the plot such as
DG°
(free energy),
DH°
(enthalpy), Tm (the midpoint of thermally-induced
unfolding) and m, a parameter that describes
exposure of buried surface area as a function of
denaturant concentration. It is also possible to
identify stable partially unfolded forms of the
protein (folding intermediates) that can provide
insight into the function and structural
organization of the protein. We can take advantage
of the presence of aromatic amino acid side chains
in the protein to monitor unfolding by a variety of
spectroscopic methods including fluorescence
emission, ultraviolet, and circular dichroism
spectroscopy. These spectroscopic methods provide
complementary information on the tertiary and
secondary structure of the protein being studied.
Additional information can be obtained from such
techniques as enzyme activity studies,
size-exclusion chromatography and site-directed
mutagenesis.